ResearcherStanford MedicineActive in the last 2 years
Monte Meier Winslow
Matched on ORCID iD 0000-0002-5730-9573; OpenAlex author ID A5062358716; NIH RePORTER profile ID 10201426. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 5
- Labs led
- 1
- Collaborators
- 22
2013: 1 grant · 2014: none · 2015: 1 paper, 1 grant · 2016: 1 grant · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 grant · 2026: 1 paper, 1 grant
Papers 4
- Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment. Co-author DOI 10.1158/0008-5472.can-25-1969↗
- Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Co-author DOI 10.1038/s41598-018-32159-x↗
- BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer. Last author DOI 10.1158/2159-8290.cd-17-0250↗
- Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Last author DOI 10.1101/gad.264861.115↗
Grants 5
- Multiplexed dissection of metastatic ability, organ tropism, and immune evasion U01CA301426↗
- Program the Immune System against RAS-driven Cancer R61CA278398↗
- Somatic Engineering-based Models of Pancreatic Cancer R21CA194910↗
- Multiplexed in vivo drug screening: Inhibitors of metastatic seeding R21CA188863↗
- Molecular Dissection of Hmga2 Function during Pancreatic Cancer Progression AWARD pancan:2013-monte-winslow-phd-molecular-dissection-of-hmga2-function-d
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dmitri Petrov · 1 shared paper, 1 shared grant, 2026 · strength 1.49
- Xiaojing J Gao · 1 shared grant, 2025 · strength 1.07
- Sohinee Bhattacharyya · 1 shared paper, 2026 · strength 0.23
- Sofia Ferreira · 1 shared paper, 2026 · strength 0.23
- Brittany M. Flowers · 1 shared paper, 2026 · strength 0.23
- Ghmkin Hassan · 1 shared paper, 2026 · strength 0.23
- Mara H. Sherman · 1 shared paper, 2026 · strength 0.23
- Laura DeLong Wood · 1 shared paper, 2026 · strength 0.23
- Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.23
- Valerie Marie Weaver · 1 shared paper, 2026 · strength 0.23
- Laura D Attardi · 1 shared paper, 2026 · strength 0.23
- Matthew Bogyo · 1 shared grant, 2015 · strength 0.21
- Shin‐Heng Chiou · 3 shared papers, 2015–2018 · strength 0.18
- Paper Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. DOI 10.1038/s41598-018-32159-x↗
- Paper BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer. DOI 10.1158/2159-8290.cd-17-0250↗
- Paper Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editi… DOI 10.1101/gad.264861.115↗
- Barbara M. Grüner · 3 shared papers, 2015–2018 · strength 0.18
- Paper Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. DOI 10.1038/s41598-018-32159-x↗
- Paper BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer. DOI 10.1158/2159-8290.cd-17-0250↗
- Paper Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editi… DOI 10.1101/gad.264861.115↗
- Albert C. Koong · 2 shared papers, 2017–2018 · strength 0.14
- Margaret M. Kozak · 2 shared papers, 2017–2018 · strength 0.14
- Grace Kim · 2 shared papers, 2015–2017 · strength 0.10
- Madeleine Dorsch · 1 shared paper, 2018 · strength 0.09
- Amato J. Giaccia · 1 shared paper, 2017 · strength 0.06
- Crissy Dudgeon · 1 shared paper, 2015 · strength 0.04
- Ian Paul Winters · 1 shared paper, 2015 · strength 0.04
- Darren R. Carpizo · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.